Document and Entity Information
Document and Entity Information | Oct. 28, 2021 |
Cover [Abstract] | |
Security Exchange Name | NASDAQ |
Amendment Flag | true |
Entity Central Index Key | 0001832415 |
Document Type | 8-K/A |
Document Period End Date | Oct. 28, 2021 |
Entity Registrant Name | BETTER THERAPEUTICS, INC. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-39864 |
Entity Tax Identification Number | 85-3472546 |
Entity Address, Address Line One | 548 Market Street #49404 |
Entity Address, City or Town | San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94104 |
City Area Code | (415) |
Local Phone Number | 887-2311 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock |
Trading Symbol | BTTX |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Amendment Description | This Amendment No. 1 on Form 8-K/A (“Current Report on Form 8-K/A”) amends the Current Report on Form 8-K of Better Therapeutics, Inc., f/k/a Mountain Crest Acquisition Corp. II, a Delaware corporation (the “Company” or “Combined Entity” or “MCAD”), filed on November 3, 2021 (the “Original Report”), in which the Company reported, among other events, the completion of the Business Combination between the Company and Better Therapeutics OpCo, Inc., f/k/a Better Therapeutics, Inc., a Delaware corporation (“BTX”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Original Report. |